Navigation Links
Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property
Date:12/8/2009

WELLESLEY HILLS, Mass., Dec. 8 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. Managing Partner of Finn, Warnke & Gayton announced today that the firm is offering a sales platform for biotechnology companies to sell their intellectual property. According to industry sources, many of these enterprises have intellectual property sitting dormant in various stages of development due to funding, scientific or regulatory issues.

Finn noted that the firm's experience in selling the intellectual property of ActivBiotics, Spherics, Prospect Therapeutics, Alpha Beta Technologies and Epix Pharmaceuticals has given it the opportunity to develop a database of active buyers and create a legal platform to conduct sales. It has also created a steady flow of inquires from biotech firms and individuals regarding the firm's future offerings of intellectual property.

Persons interested in discussing this service should contact Joseph F. Finn, Jr., Christopher J. Finn, or Paul Bolger at 781-237-8840 or Link';s.eVar3=s.prop5;s.prop15='78779862';s.tl(this,'o','ExternalLink');">jffinnjr@earthlink.net.

About Finn, Warnke & Gayton

For over 35 years, Finn, Warnke & Gayton has been one of the region's most respected business consulting and accounting firms. In addition to our new service, our team of professionals provides management consulting services to distressed enterprises, accounting, trustee, and agency services related to bankruptcy and insolvency matters, advisory services to financial institutions, interim management, and traditional tax and accounting services to corporations and individuals. For more information on the firm, please visit our website at Link';s.eVar3=s.prop5;s.prop15='78779862';s.tl(this,'o','ExternalLink');">finnwarnkegayton.com.

SOURCE Finn, Warnke & Gayton


'/>"/>
SOURCE Finn, Warnke & Gayton
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Spherics, Inc. Assigns Assets to Joseph F. Finn, Jr., C.P.A.
2. Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
3. Stevens to host Nanoscience/Nanotechnology & Corrosion symposium, Nov. 13
4. SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles
5. SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles
6. Polymathic Analytical Labs Debuts at World's Largest Medical Design & Manufacturing Exhibition
7. M. D. Anderson Automates Laboratory Workflow with Stone Bond Technologies : EE-LIMS™ from Stone Bond Technologies Will Document Activities within the Laboratory Workflow at the siRNA Facility, Increasing Throughput, While Reducing Risks
8. Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe
9. Ovalum Ltd. Received Clearance to Market the CiTop™ Product-Line in Israel
10. Ovalum Ltd. Announces Success in Coronary Cases Using CiTop™ ExPander™ Guidewire
11. Argonne researchers win 2 R&D 100 Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017 Aviva ... tools, announced the acquisition of GenWay Biotech Incorporated, ... comprehensive service and product offering for both the ... will facilitate growth and enhance capabilities for both ... and ELISA assays will nicely complement ASB,s objective ...
(Date:2/22/2017)...  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company ... products for companion animals, will host a live conference call ... discuss financial results from the fourth quarter and full year ... investors may access the audio webcast or use ... ...
(Date:2/22/2017)...  PrimeVax Immuno-Oncology, Inc. announced today its CEO, ... Biocom Global Life Science Partnering Conference.  The presentation will ... the Torrey Pines Lodge, in San Diego.  ... who have chosen our company, amongst numerous others, to ... and clinical researchers," said Mr. Chen. "In contrast to ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... development of precision treatments for neurodegenerative diseases, today announced it has issued a ... approach.” This is one of a series of commentaries from ProMIS’s scientific team ...
Breaking Biology Technology:
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
(Date:2/8/2017)... , Feb. 7, 2017 The ... largely by the confluence of organizations, desires to ... for knowledge-based systems (password and challenge questions), biometrics ... and government systems. The market is driven by ... demarcation between consumer and enterprise uses cases, with ...
Breaking Biology News(10 mins):